Can Multiple Sclerosis be Managed Over a Lifetime? A Rare 72-Year Journey of Pediatric-Onset to Secondary Progressive Multiple Sclerosis. [PDF]
Etemadifar M +4 more
europepmc +1 more source
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source
Ringing the Bell's: A Mohs complication worth listening to - A case report. [PDF]
Beard A, Obeime I, Don F.
europepmc +1 more source
Mind the Gap: Predictors of Osteoporosis Treatment Following Fragility Fracture in Parkinsonism
Abstract Background Fracture risk is increased in Parkinson's yet this risk is often not addressed. Objectives Our objective was to study the extent to which osteoporosis was treated, and predictors of treatment in a large representative cohort with parkinsonism.
Katie C. Naylor +2 more
wiley +1 more source
Long-term outcomes of endoscopic radiofrequency ablation for pyriform sinus fistula in children and risk factors for transient vocal cord paralysis. [PDF]
Niu H, Li B, Chai X, Li W.
europepmc +1 more source
Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease
Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels +3 more
wiley +1 more source
Post-traumatic Carotid-Cavernous Fistula Following Penetrating Orbital Injury: A Case Report and Literature Review. [PDF]
Gómez Cristancho DC +7 more
europepmc +1 more source
Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1
ABSTRACT Glutamine:fructose‐6‐phosphate transaminase 1 (GFPT1) catalyzes the first and rate‐limiting step of the hexosamine biosynthetic pathway (HBP) to generate UDP‐GlcNAc. GFPT1 exon 9 is specifically spliced in in striated muscles, which makes a long isoform of GFPT1 (GFPT1‐L).
Kinji Ohno +5 more
wiley +1 more source
Von Hippel-Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype-Phenotype Features. [PDF]
Wang Q +8 more
europepmc +1 more source
Extensive thoracic spontaneous epidural hematoma presenting with position-induced transient paraplegia: successful conservative management in the resource limited settings. [PDF]
Murakami K +3 more
europepmc +1 more source

